Katherine Cora Fazackerley

Title: Katherine Cora Fazackerley: Innovator in Prosthetic Heart Valve Technology

Introduction

Katherine Cora Fazackerley is a notable inventor based in San Mateo, CA (US). She has made significant contributions to the field of biomedical engineering, particularly in the development of prosthetic heart valves. With a total of 3 patents to her name, her work is paving the way for advancements in cardiac health.

Latest Patents

Fazackerley's latest patents include innovative materials for prosthetic heart valves. One of her patents focuses on a cultured cell leaflet material, which involves a prosthetic heart valve that can include a cultured cell tissue leaflet. This design allows for a plurality of leaflets secured together within an expandable tubular member. The cultured cell tissue is obtained by culturing fibroblast cells and smooth muscle cells to form a sheet of cultured cells, which can be chemically cross-linked while under tension. Additionally, the cultured cell tissue can be radially or bi-axially tensioned.

Another significant patent involves a kidney capsule leaflet material. This prosthetic heart valve can also include a kidney capsule tissue leaflet, which is obtained from farm animals such as cows, pigs, horses, goats, or sheep. Similar to her other patent, this kidney capsule tissue can be tensioned and chemically cross-linked to enhance its functionality.

Career Highlights

Fazackerley is currently employed at Boston Scientific Scimed, Inc., where she continues to innovate in the field of medical devices. Her work is instrumental in improving the quality of life for patients requiring heart valve replacements.

Collaborations

Some of her notable coworkers include Crystal Marie Anderson-Cunanan and Lynne E Swanson, who contribute to the collaborative environment that fosters innovation at Boston Scientific.

Conclusion

Katherine Cora Fazackerley's contributions to prosthetic heart valve technology exemplify the impact of innovative thinking in the medical field. Her patents reflect a commitment to advancing healthcare solutions that can significantly benefit patients.